Daniel Re - Publications

The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 03, 2025

Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 11, 2025

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 19, 2022

The evolution of mature cystic teratomas of the ovary into squamous cell carcinoma: two case reports and review of the literature.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: February 28, 2022

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 25, 2021

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Journal: Nature communications

Published: September 13, 2021

Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.

Journal: Leukemia & lymphoma

Published: July 26, 2021

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 01, 2021

Autoimmune haemolytic anaemia associated with COVID-19 infection.

Journal: British journal of haematology

Published: May 07, 2020

Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab.

Journal: Hematological oncology

Published: March 28, 2017

First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.

Journal: Hematological oncology

Published: August 29, 2016

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.

Journal: British journal of haematology

Published: May 08, 2016